[Clinical trials of a new anthelmintic drug (F.I. 6518) in some helminth infectious].
D000293:Adolescent; D000328:Adult; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010123:Oxyuriasis / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D007211:Indoles; D010879:Piperazines
Esperimentazione clinica di un preparato antielmintico (F.I. 6518) in alcune digestosi elmintiche.